Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Kishi T, Matsuda Y, Iwata N. Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials. PLOS ONE 2014; 9(2): e88049 Indexing Status Subject indexing assigned by NLM MeSH Adult; Antipsychotic Agents /therapeutic use; Blood Glucose /drug effects; Double-Blind Method; Heart /drug effects; Hemoglobin A, Glycosylated /metabolism; Humans; Isoindoles /adverse effects /therapeutic use; Piperazines /adverse effects /therapeutic use; Piperidines /adverse effects /therapeutic use; Randomized Controlled Trials as Topic; Risk; Schizophrenia /drug therapy /metabolism; Thiazoles /adverse effects /therapeutic use; Weight Gain /drug effects AccessionNumber 12014012915 Date bibliographic record published 26/02/2014 |